COMPUTER AIDED

FORMULATION DEVELOPMENT

M.Pharmacy II Semester,

Department of Pharmaceutics,

Contents

• Concept of Optimization

• Optimization parameters

• Factorial design, Optimization technology & Screening design.

• Computers in Pharmaceutical Formulation

• Development of Pharmaceutical Emulsions Microemulsion drug

carriers

• Legal Protection of Innovative Uses of Computers in R&D

• Reference

www.DuloMix.com

Concept of Optimization

• The term Optimize is “to make perfect”.

• It is defined as: choosing the best element from some set of available

alternatives.

• An art, process, or methodology of making something (a design,

system, or decision) as perfect, as functional, as effective as possible.

www.DuloMix.com

Terms used

❑ FACTOR: It is an assigned variable such as concentration ,

Temperature etc.,

▪ Quantitative: Numerical factor assigned to it

Ex; Concentration- 1%, 2%,3% etc.,

▪ Qualitative: which are not numerical

Ex; Polymer grade, humidity condition, etc.,

❑ LEVELS: Levels of a factor are the values or designations assigned

to the factor FACTOR LEVELS

Temperature 300 , 500

Concentration 1%, 2%

www.DuloMix.com

❑ RESPONSE: It is an outcome of the experiment.

It is the effect to evaluate. Ex: Disintegration time etc..,

❑ EFFECT: It is the change in response caused by varying the levels

▪ It gives the relationship between various factors & levels

❑ INTERACTION: It gives the overall effect of two or more variables

Ex: Combined effect of lubricant and glidants on hardness of the tablet.

www.DuloMix.com

Optimization Parameters

Optimization

Parameters

Problem type Variable

Constrained Unconstrained Dependent Independent

www.DuloMix.com

PROBLEM TYPES:

Constraint – restriction placed on a system by physical limitations or by simple

practicality.

Ex., make the hardest tablet possible, but it must disintegrate in less than 15 minutes.

Unconstraint – no restriction placed, almost nonexistent.

Ex., make the hardest tablet as possible.

VARIABLES:

Independent or primary Variables (Input variables):

⁎ Formulation and process variables directly under the control of the formulator. Ex., Level of

a given ingredient , Mixing time for a given process step.

Dependent or secondary Variables (Output variables):

⁎ Responses or the characteristics of the in-progress material or the resulting drug delivery

www.DuloMix.com

system. These are a direct result of any change in the formulation or process.

Example of dependent & independent variables

Tablet formulation

Independent variables Dependent variables

X1 Diluent ratio Y1 Disintegration time

X2 compressional force Y2 Hardness

X3 Disintegrant level Y3 Dissolution

X4 Binder level Y4 Friability

X5 Lubricant level Y5 weight uniformity

www.DuloMix.com

EXPERIMENTAL DESIGN APPLICATION AND

INTERPRETATION IN PHARMACEUTICAL

TECHNOLOGY

Introduction

• Experimental design is a concept used to organize, conduct, and interpret

results of experiments in an efficient way and useful information are

obtained by performing a small number of trials.

• Knowledge of product/process is defined by,

Design space

• It is a multidimensional combination and interaction of input variables and

process parameters, which have been demonstrated to provide assurance of

quality

www.DuloMix.com

Purposes of DoE application

• Screening studies to determine the most influential factors affecting the

product/process;

• Full or fractional designs to quantify factorial effects;

• Response surface studies particularly useful for optimization;

• Mixture designs

Theory:

• Experimental study is to find the relationships between independent variables

(factors) and dependent variables (results, outcomes) within the experimental

framework.

• Used to simultaneously study the effects of multiple independent variables (factors)

on response variable(s); therefore, it is a multivariate analysis technique.

www.DuloMix.com

Screening Designs

• Screening designs are used to identify the most influential factors.

• A huge number of factors, f , can be screened.

• Factors are varied on two levels in a relatively small number of experiments N ≥ f + 1.

• Typical two-level screening designs are fractional factorial or Plackett–Burman

designs.

• When the number of factors, f , is small, then full factorial design can also be used for

screening purposes.

• Screening designs allow simultaneous investigation of both qualitative (discrete) and

quantitative (continuous) factors.

www.DuloMix.com

• When f factors are varied on two levels, all possible combinations of these

variations make up the two-level full factorial design.

• The number of experiments, N , in this design is L f= 2 f .

• The designs are usually denoted as e f, in a 2 f design, 3 factors (f) are varied on 2

levels (e).

• The factor levels are in coded values, the lower factor level is denoted as −1, and 1

stands for the upper factor level.

www.DuloMix.com

• The experiments are conducted and results are used to calculate factor effects.

• The factor effects demonstrate to what extent certain factors influence the output (i.e.

studied dependent variable).

• Factor effects are used to build the regression model

where y is the response (dependent variable), β0 the intercept, and βi the regression

coefficients (regression coefficients stand for factor effects).

www.DuloMix.com

• Full factorial designs allow identification of factor interactions.

• Independent variables, that is, factors can interact meaning that the influence of one

factor on the response is different at different levels of another factor(s).

• Fractional factorial designs are denoted as 2 f-v, where 2 − v (1/2 v ) represents the

fraction of experiments from the full factorial designs that are omitted ( v = 1, 2, 3 .

. .)

• An example of fractional factorial design for 4 factors, 2 4-1 design. By fractioning

the combinations of factors levels, some of the information is lost.

www.DuloMix.com

• Fractional factorial design does not indicate potential factor interactions and if it is

highly fractioned, some factors effects are estimated together (factors are

confounded).

• The Plackett–Burman design, allows estimation of factor effects for f = N – 1

factors, where N is the number of experiments with a multiple of 4.

• These designs are especially useful for preliminary investigations of huge numbers

of potentially influential factors , for a 2 7-4 design.

• Other special kinds of screening designs are asymmetrical, supersaturated, or

mixed-level designs.

• D-optimal design can also be adapted for screening purposes.

www.DuloMix.com

Response surface designs

• Response surface designs are used to analyze effects of the most significant factors that

are recognized by screening studies.

• The number of factors is usually 2 or 3.

• Factors are varied on at least three levels.

• The main goal of response surface designs is optimization.

• Qualitative (discrete) factors cannot be used.

• Response surface designs are accompanied by visual representation of the factors’

influence on the studied response.

www.DuloMix.com

Response surface designs

Symmetrical designs Asymmetrical designs

Box-

Three-level Central

Behnken

full factorial composite

design

www.DuloMix.com

Three-level full factorial

• Three-level full factorial design for three factors is represented in figure

• In order to determine the experimental error, the central point is often replicated

several (3–5) times.

www.DuloMix.com

Central composite design (CCD)

• Central composite design (CCD) is composed of

– two-level full factorial design (2fexperiments),

– a star design (2 f experiments), and

– A center point.

• N = 2 f + 2 f + 1 experiments to examine the f factors

• The points of the full factorial design are situated at factor levels −1 and +1, those of the

star design at the factor levels 0, − α and + α , and the center point at factor level 0.

• Depending on the value of α , two types of designs exist,

• A face-centered CCD (FCCD) with | α | = 1, and

• A circumscribed CCD (CCCD) with | α | > 1

• In the case of FCCD and CCCD, factors are varied on three or five levels, respectively.

www.DuloMix.com

Box-Behnken design

• A BBD is described for a minimum of three factors

• Contains N = (2 f ( f − 1)) + c 0 experiments, c 0 is the number of center points

• Most common alternative to the CCD .

• BBDs are second-order designs based on three-level incomplete factorial designs.

• BBD can be presented in a simplified manner as follows

www.DuloMix.com

• When there are 5 or more factors, Box and Behnken recommended using all

possible 23 designs, holding the other factors constant.

• Advantages of BBD is that it does not contain combinations for which all factors

are simultaneously at their highest or lowest levels.

www.DuloMix.com

Doehlert (uniform shell) design

• A Doehlert (uniform shell) design has equal distances between all neighbouring

experiments

• Factors are varied at different numbers of levels, in the same design.

• Enables to select the number of levels for each factor, depending on its nature and

desired experimental domain.

• The Doehlert design describes a spherical experimental domain and stresses

uniformity in space filling.

• For two variables, the design consists of one central point and six points forming a

regular hexagon, and therefore is situated on a circle.

• One variable is varied on five levels, whereas the other is varied on three levels.

• The efficiency of one experimental design is defined as the number of

coefficients in the estimated model divided by the number of experiments.

www.DuloMix.com

• Asymmetrical designs are used for investigation in the asymmetrical experimental domain.

• Typical examples are D-optimal design.

D-Optimal design:

• D-optimal design is an efficient tool in experimental design.

• Detect the best subset of experiments from a set of candidate points.

• N experiments forming the D-optimal design are selected from the candidate points,

forming a grid over the asymmetrical domain.

• These experiments are the best subset of experiments selected from a candidate set.

www.DuloMix.com

The best subsets are selected by the criterion that the selected design should maximize

the determinant of the matrix X’X for a given regression model. These designs are

referred to as D (from ‘D’ in determinant)

• In all of the above described response surface designs, the regression model is

defined as:

• where y is the response, β 0 the intercept, β i the main coefficients, β ij the two

factor interaction coefficients, and β ii the quadratic coefficients.

www.DuloMix.com

Mixture Designs

• Mixture designs are used to study mixture variables such as excipients in a formulation.

• All mixture components are examined in one design.

• The characteristic feature of a mixture is that the sum of all its components adds up to

100%, hence cannot be manipulated completely independently of one another.

• Data analysis is more complicated, since mixture factors are correlated.

www.DuloMix.com

• Simplex lattice mixture designs can be defined with three or six experiments

(experiments 1–6 in table).

• If experiment 7 is included, then it is a simplex lattice-centroid design and

• If all ten experiments are considered, then it is an augmented simplex lattice–centroid

mixture design.

Experimental points for the mixture design

www.DuloMix.com

• The three most commonly used mixture designs support

Linear models

– Taken from the axial design.

– Used for screening (or) robustness testing.

Quadratic & Special cubic models

– Derived from simplex centroid designs.

– Used for Optimization purposes.

Three most commonly used mixture desings for three-component mixtures supporting

linear(left), quadratic(center), and spewcwiawl.D cuulobMiixc.c(ormight) models.

• Mixture designs are of K – 1 dimensionality, where K is the number of factors (mixture

components).

• The mixture regions of regular mixtures

– Two component mixtures-line,

– Three component mixtures-triangle,

– Four-component mixtures- tetrahedron.

Constraints are made, due to limitations in mixture components.

• Then constraints are defined (e.g. all three mixture components must be present, and

weight ratio of one of the components should not exceed a certain percentage, etc.).

www.DuloMix.com

• Domains of different shape within the triangle (tetrahedron, etc.) are then selected.

– Regular mixture designs no longer apply,

– Irregularity in experimental design is best handled with D-optimal design.

• D-optimal design maps the largest possible experimental design for selected model

(linear, quadratic, or special cubic).

• It is therefore necessary to carefully define the purpose of experimental study

(screening, optimization, or robustness testing) prior to selection of adequate

mixture design.

www.DuloMix.com

COMPUTERS IN FORMULATION

DEVELOPMENT

Introduction

• Over the past decade a small number of visionary scientists have been experimenting with

and developing advanced computing techniques.

• These include

– Expert and knowledge-based systems

– Neural computing

– Computer simulation

The idea behind this work is

– to assist the formulation of products with the added benefits of consistent decision

making, decreased timelines, and cost savings.

www.DuloMix.com

Expert and Knowledge-based Systems

• “An expert system is a knowledge-based system that emulates expert thought to solve

significant problems in a particular domain of expertise.”

• “An expert system is a computer program that draws upon the knowledge of human

experts captured in a knowledge base to solve problems that normally require human

expertise.”

• Expert systems comprise an interface allowing a two way communication between the

user and the system.

• A knowledge base where all the knowledge pertaining to the domain is stored and an

inference engine where the knowledge is extracted and manipulated to solve the

problem in hand.

• Inferencing strategies may be

– Forward chaining

– Backward chaining

www.DuloMix.com

• Other representation methodologies may include

– frames or templates; semantic networks; and decision trees or tables for

organizing knowledge in a tree or tabular format.

• Generally, multiple methods are used to express formulation knowledge.

• Expert Systems can be developed with conventional computer languages such as C

or more recently JAVA, with specialized languages such as LISP and PROLOG, or

with the assistance of development shells or toolkits.

• Shells and toolkits are sets of programs written in either conventional or specialized

languages that can form an expert system when loaded with knowledge.

• They compromise on applicability and flexibility but allow the rapid development

of unique systems.

www.DuloMix.com

• The technology is generally referred to as rule-based reasoning (RBR) because it

relates to the structuring and use of knowledge in the form of rules abstracted

during the acquisition process.

• Another technology used to develop expert systems is case-based reasoning (CBR):

To solve a problem, remember a similar problem you have solved in the past and

adapt the solution to solve the new problem [7]. CBR directly uses records of

previous solutions both successful and unsuccessful as its principal knowledge base.

www.DuloMix.com

Neural Computing

• The properties of a formulation are determined not only by the ratios in which the

ingredients are combined but also by the processing conditions.

• Formulators have tended to use statistical techniques such as a response surface

methodology to investigate the design space, but optimization by such a method can be

misleading, especially if the formulation is complex.

• Recent advances in mathematics and computer science have resulted in the development

of three techniques,

– Neural networks

– Genetic algorithms

– Fuzzy logic

www.DuloMix.com

Neural networks

• Like humans, neural networks learn directly from input data.

• The learning algorithms take two main forms,

– Unsupervised Learning:

– Supervised Learning

• The basic component of the neural network is the neuron, a simple mathematical

processing unit that takes one or more inputs and produces an output.

• The neuron simply computes the weighted sum of all the outputs and calculates an output.

• Output is then modified by means of a transformation function (PERCEPTRON- simple

processing unit, a feed-forward system from inputs to outputs, only)

www.DuloMix.com

• A neural network consists of many neurons organized into a structure called the network

architecture.

• Most popular and successful is the multilayer perceptron (MLP) network.

Optimization technique based on concepts of biological evolution.

• Require a concept of “fitness,” which is assessed by user-specified goals.

• Genetic algorithms work with a population of individuals, each of which is a candidate

solution to the problem.

www.DuloMix.com

Genetic Algorithms

• Each individual’s “fitness” is assessed, and if an optimum solution is not found, then a

further generation of possible solutions is produced by combining large chunks of the

fittest initial solutions by a crossover operation (mimicking mating and reproduction).

• After many generations, an optimum solution will be found.

www.DuloMix.com

Fuzzy logic

• In defining the concept of “fitness,” fuzzy logic provides a useful framework for

describing complex formulation goals.

• Fuzzy logic, as the name implies, blurs the clear-cut “true” and “false” of conventional

“crisp” logic by assigning a noninteger number that describes the “membership” in a

particular set as somewhere between 0 (false) and 1 (true)

• If the formulator is seeking a tablet with a disintegration time of less than 300 seconds,

one with a disintegration time of (say) 310 seconds will not be rejected out, but will be

assigned a desirability of somewhat less than 100% according to its membership in the

Low set.

www.DuloMix.com

COMPUTER SIMULATION

• Simulation is best described as the process of translating a real system into a

working model in order to run experiments.

• A simulation does not duplicate a system; rather it is an abstraction of reality using

mathematics to express cause-and-effect relationships that determine the behaviour

of the system.

• Software for computer simulation is often customized and based on that developed

in academia.

• There are not many commercial packages available for Pharmaceutical formulation.

www.DuloMix.com

DEVELOPMENT OF PHARMACEUTICAL

EMULSIONS, MICROEMULSION DRUG

CARRIERS

Introduction

• Concept of formulation development assisted by computer applications.

• Due to complex composition, preparation and stability issues of emulsions were selected to

showcase various computer- aided tools in pharmaceutical formulation development.

• Successful development of an emulsion formulation is dependent on both formulation

ingredients and processing parameters.

• The examples provided illustrate techniques

– Used to define a design space,

– Select the appropriate formulation ingredient,

– Optimize the formulation composition and process parameters, according to the quality-

by-design (QbD) concept.

• Importantly, methods that allow simultaneous optimization of multiple factors are also

presented.

• Provide a deeper insight into selected inw wswil.DiculooM mix.ecothmods.

•

Application of Computer- aided techniques in

development of Pharmaceutical Emulsions

• Emulsions are disperse systems made of two immiscible liquids.

• One liquid is dispersed into the other, in the presence of surface active agents, such as

emulsifier(s).

• The two immiscible liquids are usually oil and water.

• The main types of simple emulsions are oil- in-water (o/w) or water- in-oil (w/o).

• Emulsions have a great potential as vehicles for active ingredients for different routes of

administration (topical, parenteral, oral).

www.DuloMix.com

Application of different in silico techniques in process

and formulation optimization

• Factorial design methods to optimize the stability and suggested the required hydrophilic

lipophilic balance (HLB) of o/w emulsions prepared with sodium lauryl sulfate as the

surfactant.

• Influence of the processing variables on performance of o/w emulsion gels stabilized by a

polymeric emulsifier (Pemulen® TR-2NF). A two-factor three-level experimental design at

two sets was applied.

• Optimal preservative combination and concentration for preparing topical emulsions by using

a D-optimal experimental design (mixture design).

• Influence of different ratios of individual components on the viscoelastic behaviour of

semisolid lipophilic emulsion systems using ANN technique.

• Formulation optimization of the w/o/w multiple emulsion incorporating insulin was

performed, based on statistical methods such as the orthogonal experimental design and the

response surface evaluation.

www.DuloMix.com

Application of computer- aided techniques in

development of microemulsion drug carriers

• Microemulsions are thermodynamically stable and optically isotropic transparent colloidal

systems consisting of water, oil, and surfactant.

• Although they are clear, low viscous liquids, the different types of microstructures are

identified (i.e. w/o, o/w, and bicontinuous), all organized on the level below 100 nm.

• Microemulsions and self- microemulsifying drug delivery systems (SMEDDS) form only

in well balanced mixtures of the selected excipients and within the specific concentration

ranges of the constituents at given temperatures and pressures (i.e. the microemulsion

area)

• ANN models were introduced as useful tools for accurate differentiation and prediction of

the microemulsion area.

www.DuloMix.com

LEGAL PROTECTION OF

INNOVATIVE USES OF COMPUTERS IN R&D

INTELLECTUAL PROPERTY RIGHTS (IPR)

⸭ The term “Intellectual Property Rights” is used to describe the legal instruments for

protecting innovation.

⸭ Almost all countries recognize the basic types of laws governing intellectual property

rights.

⸭ Member states of the World Trade Organisation have all committed to introduce IPR.

www.DuloMix.com

Types of Intellectual Property Rights (IPR)

Type of IPR Protects Maximum Lifetime

(generally—may vary

from country to country)

Patent Technical ideas 20 years from filing

Copyright Literary works including computer programs 70 years from death of author or date of

creation (in the case of joint works)

Database rights Collection of data (only exists in the European 70 years from the date of creation

Union and some other countries—the US is

discussing the proposal)

Trade secrets Secret nondisclosed information Unlimited, as long as access is limited to a

select group.

Design Aesthetic creation (generally not relevant in the Varies from country to country; 25 years in

pharmaceutical field) the European Union from application; 14

years in the United States from grant.

Trademarks Brand name or sign Unlimited, as long as the

designating a productwww.DuloMix.com trademark remains in use

Enforcement of Rights

• Obtaining IP protection is only the first step.

• The intellectual property rights obtained are only useful if they can be exploited

and—ultimately—unauthorized users of the rights can be stopped from exploiting

them.

• This presents a fairly unique problem in the computer science field.

• IP rights are essentially national rights.

• They are only valid in the country in which they are granted or registered.

• Any scientist using unauthorized patented computer software in pharmaceutical

research and development would be infringing the patent even if the computer (for

example, a database server) was located in another country.

www.DuloMix.com

Conclusion

• The use of computers in developing new pharmaceutical products is nowadays

commonplace, and a number of tools and databases have been developed to

improve their use.

• Although intellectual property rights have to date rarely been the subject of court

cases, protection is available and the courts are prepared to enforce these rights,

even in an international context.

www.DuloMix.com

REFERENCE

• Computer Applications in Pharmaceutical Research and

Development, Sean Ekins, 2006, John Wiley & Sons.

• Computer-Aided Applications in Pharmaceutical Technology, 1st

edition, Jelena Djuris, Woodhead Publishing

• Modern Pharmaceutics; By Gillbert and S. Banker.

www.DuloMix.com

www.DuloMix.com